Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 2
2013 1
2017 1
2018 2
2019 1
2020 2
2021 5
2022 5
2023 6
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).
Esmail A, Oelofse S, Lombard C, Perumal R, Mbuthini L, Goolam Mahomed A, Variava E, Black J, Oluboyo P, Gwentshu N, Ngam E, Ackerman T, Marais L, Mottay L, Meier S, Pooran A, Tomasicchio M, Te Riele J, Derendinger B, Ndjeka N, Maartens G, Warren R, Martinson N, Dheda K. Esmail A, et al. Among authors: oelofse s. Am J Respir Crit Care Med. 2022 May 15;205(10):1214-1227. doi: 10.1164/rccm.202107-1779OC. Am J Respir Crit Care Med. 2022. PMID: 35175905 Clinical Trial.
A breath of relief: High-flow nasal oxygen in a resource-limited setting.
Kühn L, Esmail A, Oelofse S, Dheda K. Kühn L, et al. Among authors: oelofse s. Afr J Thorac Crit Care Med. 2022 May 5;28(1):10.7196/AJTCCM.2022.v28i1.223. doi: 10.7196/AJTCCM.2022.v28i1.223. eCollection 2022. Afr J Thorac Crit Care Med. 2022. PMID: 35647525 Free PMC article. No abstract available.
Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial.
Esmail A, Randall P, Oelofse S, Tomasicchio M, Pooran A, Meldau R, Makambwa E, Mottay L, Jaumdally S, Calligaro G, Meier S, de Kock M, Gumbo T, Warren RM, Dheda K. Esmail A, et al. Among authors: oelofse s. Nat Med. 2023 Apr;29(4):1009-1016. doi: 10.1038/s41591-023-02247-1. Epub 2023 Mar 9. Nat Med. 2023. PMID: 36894651 Clinical Trial.
Waste Disposal Practices in Low-Income Settlements of South Africa.
Haywood LK, Kapwata T, Oelofse S, Breetzke G, Wright CY. Haywood LK, et al. Among authors: oelofse s. Int J Environ Res Public Health. 2021 Aug 2;18(15):8176. doi: 10.3390/ijerph18158176. Int J Environ Res Public Health. 2021. PMID: 34360468 Free PMC article.
SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset.
Tomasicchio M, Jaumdally S, Wilson L, Kotze A, Semple L, Meier S, Pooran A, Esmail A, Pillay K, Roberts R, Kriel R, Meldau R, Oelofse S, Mandviwala C, Burns J, Londt R, Davids M, van der Merwe C, Roomaney A, Kühn L, Perumal T, Scott AJ, Hale MJ, Baillie V, Mahtab S, Williamson C, Joseph R, Sigal A, Joubert I, Piercy J, Thomson D, Fredericks DL, Miller MGA, Nunes MC, Madhi SA, Dheda K. Tomasicchio M, et al. Among authors: oelofse s. Am J Respir Crit Care Med. 2024 Apr 1;209(7):840-851. doi: 10.1164/rccm.202308-1438OC. Am J Respir Crit Care Med. 2024. PMID: 38226855 Free PMC article.
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, Briner C, Kwatra G, Ahmed K, Aley P, Bhikha S, Bhiman JN, Bhorat AE, du Plessis J, Esmail A, Groenewald M, Horne E, Hwa SH, Jose A, Lambe T, Laubscher M, Malahleha M, Masenya M, Masilela M, McKenzie S, Molapo K, Moultrie A, Oelofse S, Patel F, Pillay S, Rhead S, Rodel H, Rossouw L, Taoushanis C, Tegally H, Thombrayil A, van Eck S, Wibmer CK, Durham NM, Kelly EJ, Villafana TL, Gilbert S, Pollard AJ, de Oliveira T, Moore PL, Sigal A, Izu A; NGS-SA Group; Wits-VIDA COVID Group. Madhi SA, et al. Among authors: oelofse s. N Engl J Med. 2021 May 20;384(20):1885-1898. doi: 10.1056/NEJMoa2102214. Epub 2021 Mar 16. N Engl J Med. 2021. PMID: 33725432 Free PMC article. Clinical Trial.
Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants.
Jaumdally S, Tomasicchio M, Pooran A, Esmail A, Kotze A, Meier S, Wilson L, Oelofse S, van der Merwe C, Roomaney A, Davids M, Suliman T, Joseph R, Perumal T, Scott A, Shaw M, Preiser W, Williamson C, Goga A, Mayne E, Gray G, Moore P, Sigal A, Limberis J, Metcalfe J, Dheda K. Jaumdally S, et al. Among authors: oelofse s. Nat Commun. 2024 Mar 5;15(1):2003. doi: 10.1038/s41467-024-45400-1. Nat Commun. 2024. PMID: 38443359 Free PMC article.
Integrating molecular and radiological screening tools during community-based active case-finding for tuberculosis and COVID-19 in southern Africa.
Scott AJ, Limbada M, Perumal T, Jaumdally S, Kotze A, van der Merwe C, Cheeba M, Milimo D, Murphy K, van Ginneken B, de Kock M, Warren RM, Gina P, Swanepoel J, Kühn L, Oelofse S, Pooran A, Esmail A, Ayles H, Dheda K. Scott AJ, et al. Among authors: oelofse s. Int J Infect Dis. 2024 Aug;145:107081. doi: 10.1016/j.ijid.2024.107081. Epub 2024 May 1. Int J Infect Dis. 2024. PMID: 38701914 Free article.
28 results